Analýza PFE - neutrální za 2 roky kolem 31,20 USD za kus
https://docs.google.com/spreadsheets/d/1PHqoAfA_lFAMQnAPFt3pihQMg26hLr38mqQnCKLx54M/edit?usp=sharing
Je to zadlužené: In 2023, Pfizer's significant increase in debt was primarily due to its strategic acquisition of Seagen Inc., a biotechnology company specializing in cancer treatments. Pfizer raised approximately $31 billion through its largest debt offering to finance this $43 billion acquisition. The move is part of Pfizer's broader strategy to expand its oncology portfolio and strengthen its position in the cancer treatment market. This acquisition and subsequent debt raise reflect Pfizer's commitment to investing in high-potential growth areas despite the financial leverage increase


Žádné komentáře:
Okomentovat